Creative Planning boosted its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 22.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 39,137 shares of the company’s stock after acquiring an additional 7,114 shares during the quarter. Creative Planning owned about 0.05% of SIGA Technologies worth $264,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of SIGA Technologies by 1.9% during the first quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after purchasing an additional 41,515 shares during the period. AltraVue Capital LLC raised its position in SIGA Technologies by 6.6% during the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after buying an additional 134,450 shares during the last quarter. Tidal Investments LLC acquired a new stake in SIGA Technologies during the 1st quarter valued at approximately $157,000. Hillsdale Investment Management Inc. purchased a new stake in shares of SIGA Technologies in the 1st quarter valued at $1,367,000. Finally, American Century Companies Inc. boosted its holdings in shares of SIGA Technologies by 251.2% in the 2nd quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock valued at $6,389,000 after acquiring an additional 602,091 shares during the last quarter. Hedge funds and other institutional investors own 55.40% of the company’s stock.
SIGA Technologies Price Performance
Shares of SIGA Technologies stock opened at $7.57 on Friday. The stock has a market cap of $540.27 million, a PE ratio of 6.47 and a beta of 0.89. The firm has a fifty day moving average price of $7.31 and a 200 day moving average price of $8.06. SIGA Technologies, Inc. has a 1 year low of $4.26 and a 1 year high of $12.83.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
- Five stocks we like better than SIGA Technologies
- Basic Materials Stocks Investing
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 11/4 – 11/8
- Why Are Stock Sectors Important to Successful Investing?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.